Promoter Acquirer Increases Stake in Goldline Pharmaceutical Ltd Through Open Market Purchase
Swapan Khandelwal, a Whole Time Director and Promoter of Goldline Pharmaceutical Limited, has increased his stake in the company following an open market purchase on June 22, 2026.The promoter acquired 60,000 equity shares of Goldline Pharmaceutical Limited. This transaction represents 0.62% of the total paid-up shares capital of the company.Prior to the acquisition, Mr. Khandelwal's holding stood at 2,749,988 shares, equating to 28.65% of the company’s total paid-up share capital.Following the purchase, his cumulative holding increased to 2,809,988 shares, which corresponds to a 29.27% stake in Goldline Pharmaceutical Limited.The...